Contact this trialFirst, we need to learn more about you.
Vasopressor
Angiotensin II for Septic Shock
Recruiting3 awardsPhase 4
Iowa City, Iowa
This trial aims to enroll 20 patients with septic shock who need immediate medication support in the emergency department. The main goal is to see if giving angiotensin II early through a vein after
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service